Protalix BioTherapeutics (PLX)

6.28 +0.20  +3.29%  May 25, 11:00PM Go Pro
Watch this stock
View Full Chart PLX Price Chart

Key Stats

Market Cap 570.35M
Revenue Growth -37.87%
Profit Margin -158.4%
Earnings Yield -7.01%
Dividend Yield 0.00%
Earnings Per Share TTM -0.44
PE Ratio
Price / Sales Ratio 819.47
52 Week High 7.70
52 Week Low 4.06
Beta 1.592
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

May 10 @groberjg07 $ARNA $PLX immediately opened on FDA approval and yet we are still halted.. by BiopharmaPro
May 10 $PLX in. by Captain_Power
May 10 $PLX http://stks.co/3lrN recovery after the Approval profit taking, will be volatile till the option expiry 5/19 by gantosj
May 10 $idix $affy $PLX green by Judbre
May 10 PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure
May 10 Protalix BioTherapeutics to Present at Three Upcoming Healthcare Conferences GlobeNewswire
May 09 PROTALIX BIOTHERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
May 09 Selling An FDA Approval: Recent Results
May 09 $PLX the best part is the massive insider selling upon approval by johnkelly
May 09 $PLX LMFAO by johnkelly
May 08 This Biopharmaceutical Could Be Something Special

Profile

Exchange: AMEX       Sector: Healthcare       Industry: Biotechnology

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Protalix BioTherapeutics is down 0.63% over the last year vs S&P 500 Total Return up 2.03%, iBio down 58.63%, and GTx down 47.52%.

  • PLX Total Returns
  • ^SPXTR Total Returns
  • IBIO Total Returns
  • GTXI Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Balance Sheet View Statement

Get Quote for

Pro Strategies Featuring PLX

Did Protalix BioTherapeutics make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

PLX Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
PLX 6.28 +0.20 +3.29% 570.35M
PLPC 55.51 -0.28 -0.50% 295.87M
PLL 56.95 -1.41 -2.42% 6.573B
PLCM 10.79 +0.02 +0.19% 1.915B
PKN 14.79 -0.04 -0.27%
PHX 26.19 -0.56 -2.09% 216.33M
PHI 53.55 -0.12 -0.22% 11.48B
PGI 8.29 +0.10 +1.22% 415.83M
PG 62.49 -0.08 -0.13% 172.12B
PFS 14.36 +0.02 +0.14% 871.65M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close